shalinivinod13 Profile Banner
Shalini Vinod Profile
Shalini Vinod

@shalinivinod13

Followers
868
Following
2K
Statuses
2K

Radiation Oncologist l Conjoint Professor UNSW l Fitness Freak l Own views l #LCSM #BCSM #quality #radonc

Joined August 2020
Don't wanna be here? Send us removal request.
@shalinivinod13
Shalini Vinod
20 hours
@drdavidpalma @th1loz @IJROBP 👏🏽👏🏽👏🏽 Great work @th1loz et al. Just embarking on what we call the SimulatiOn Free palliaTive RadioTherapy (SOFT RT) at our centre, drawing from your teams experience.
0
0
3
@shalinivinod13
Shalini Vinod
10 days
Time for a RCT comparing hypofractionation 55/20 vs conventional fractionation 60/30 for Stage III NSCLC? @yysoon01 @Eric73363938 @HegiFiona @TROGfightcancer Any 🇦🇺 med oncs interested in joining our team?
1
4
7
@shalinivinod13
Shalini Vinod
10 days
RT @TheLancetOncol: Online First: New Research: Global #LINAC requirements and personalised country recommendations: a cross-sectional, po…
0
5
0
@shalinivinod13
Shalini Vinod
2 months
RT @Mat_Guc: Remember the misleading press reports about "brutal" #radonc after PROSPECT ? This is what modern radiotherapy can achieve fo…
0
35
0
@shalinivinod13
Shalini Vinod
2 months
👏🏽👏🏽👏🏽Amazing to see incorporation of frailty screening (G8) in assessment & reporting. Should be standard for all #clinicaltrials recruiting older people. @SIOGorg
@Icro_Meattini
Icro Meattini
2 months
Single-modality endocrine therapy versus #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #BreastCancer (EUROPA) @TheLancetOncol ▶️ Share Link – 50 days' free access to the article (Jan 31, 2025):
0
2
7
@shalinivinod13
Shalini Vinod
2 months
RT @piet_ost: I think everyone should read this review of radiotherapy vs systemic trials and endpoints selected. Why is the world focused…
0
30
0
@shalinivinod13
Shalini Vinod
2 months
RT @gwalls89: Thoracic RadOncs should check out our paper in this month's Clinical Oncology We worked with the I…
0
6
0
@shalinivinod13
Shalini Vinod
2 months
RT @NiuSanford: Our comprehensive assessment of NCI cooperative group trials is out in @JNCI_Now! If you are involved or enrolling in coo…
0
60
0
@shalinivinod13
Shalini Vinod
2 months
RT @HegiFiona: Lung cancer breakthroughs made 2024 one of the most consequential years for lung cancer researchers and clinicians. Join h…
0
6
0
@shalinivinod13
Shalini Vinod
2 months
RT @Mat_Guc: Radiation Oncology is characterized by rapid innovation Dissemination & implementation are important aspects to bring this pr…
0
16
0
@shalinivinod13
Shalini Vinod
2 months
RT @MCWardMD: Why is radiation held to a higher standard than drugs??
0
7
0
@shalinivinod13
Shalini Vinod
2 months
🙏🏽 @IASLC for showcasing our nurse led geriatric oncology model of care for older patients with #lungcancer. Study Demonstrates Multidisciplinary Approach Can Improve Care for Elderly Lung Cancer Patients @NicoleHKnox @meera_agar @DrLouiseHickman
1
1
4
@shalinivinod13
Shalini Vinod
2 months
👏🏽👏🏽👏🏽 @NicoleHKnox on 1st PhD pub. Examining unmet needs in older adults with lung cancer @NicoleHKnox @meera_agar @DrLouiseHickman
0
2
8
@shalinivinod13
Shalini Vinod
2 months
@rayychan @alexchan928 @CancerAustralia @AmericanCancer @NCCN @CancerCareMASCC @ASCO @NCICareDelivRes @AndreasC466 @COSAoncology @Flinders Given the majority of studies were from USA, did you look at effects in a universal vs non-universal health care system? Does better access to care impact on the outcomes?
1
0
3
@shalinivinod13
Shalini Vinod
2 months
RT @IASLC: Angeline Low is not just a survivor—she’s a powerful voice for lung cancer awareness and advocacy! In her heartfelt message, she…
0
2
0
@shalinivinod13
Shalini Vinod
2 months
RT @TOGAANZ: Lung cancer is the leading cause of cancer death in women. Don't ignore the signs! Thanks for coming on the journey with us t…
0
4
0
@shalinivinod13
Shalini Vinod
2 months
RT @_ShankarSiva: @targetingcancer nails it again - a compelling story about the ease of curing #lungcancer with SABR! 👀-
0
4
0
@shalinivinod13
Shalini Vinod
2 months
Thought provoking Danish study. MDTs cornerstone of oncology Rx esp #lungcancer. Dist’n of 60 fictitious cases shows poor agreement on stage & Rx intent esp St III NSCLC. Urgent need for #quality indicators to measure process & outcomes ⁦@AusLucap
0
0
2
@shalinivinod13
Shalini Vinod
2 months
RWD from 🇨🇳on the % of unresectable patients with St III NSCLC whose cancers become resectable post chemoIO. 30% of cancers remain unresectable! Caution advised on using neoadjuvant approach for these cases. @DrewMoghanaki @BrendonStilesMD
0
0
2
@shalinivinod13
Shalini Vinod
2 months
Medical mistrust is a barrier to #lungcancer screening regardless of race in 🇺🇸Food for thought with upcoming #lungcancer screening in 🇦🇺⁦@CancerAustralia⁩ ⁦@nicole_rankin8n
0
2
6